Literature DB >> 28510632

Hepatitis C Virus Relapse 78 Weeks After Completion of Successful Direct-Acting Therapy.

Céline Boschi1, Philippe Colson1, Hervé Tissot-Dupont1, Emmanuelle Bernit2, Danielle Botta-Fridlund3, Sarah Aherfi1.   

Abstract

Mesh：

Year:  2017        PMID： 28510632     DOI： 10.1093/cid/cix457

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  3 in total

1.  HCV very late relapse following an atypical viral kinetics in a HIV patient treated for hepatitis C with direct-acting antivirals.

Authors:  Viola Guardigni; Valeria Cento; Stefano Ianniruberto; Lorenzo Badia; Marianna Aragri; Matteo Conti; Carlo Federico Perno; Pierluigi Viale; Francesca Ceccherini-Silberstein; Gabriella Verucchi
Journal:  Infection       Date:  2018-05-26       Impact factor: 3.553

2.  Concordance of SVR12, SVR24 and SVR durability in Taiwanese chronic hepatitis C patients with direct-acting antivirals.

Authors:  Chuan-Pin Lin; Po-Cheng Liang; Ching-I Huang; Ming-Lun Yeh; Po-Yao Hsu; Cheng-Ting Hsu; Yu-Ju Wei; Ta-Wei Liu; Ming-Yen Hsieh; Nai-Jen Hou; Tyng-Yuang Jang; Yi-Hung Lin; Chih-Wen Wang; Zu-Yau Lin; Shinn-Cherng Chen; Chung-Feng Huang; Jee-Fu Huang; Chia-Yen Dai; Wan-Long Chuang; Ming-Lung Yu
Journal:  PLoS One       Date:  2021-02-04       Impact factor: 3.240

Review 3.  Occult Infection with Hepatitis C Virus: Looking for Clear-Cut Boundaries and Methodological Consensus.

Authors:  Anna Wróblewska; Krzysztof Piotr Bielawski; Katarzyna Sikorska
Journal:  J Clin Med       Date:  2021-12-14       Impact factor: 4.241
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.